Chris Behrenbruch

Telix Pharmaceuticals

Dr. Chris Behrenbruch is the Managing Director and Group CEO of Telix Pharmaceuticals. With over two decades of experience in radiopharmaceuticals and biotech, he holds a DPhil in biomedical engineering from the University of Oxford, an executive MBA jointly awarded from New York University, HEC Paris and the London School of Economics (TRIUM Program), and a Juris Doctor from the University of Melbourne. He has led multiple global healthcare ventures and champions purpose-driven leadership.